[The third generation of b-blockers: new possibilities ].
Iagenskiĭ
A V
AV
Barsukov
B P
BP
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D017272:Celiprolol / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D008075:Lipoproteins, HDL / Q000097:blood / Q000187:drug effects; D008077:Lipoproteins, LDL / Q000097:blood / Q000187:drug effects; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D017272:Celiprolol
Treté pokolenie beta-blokatorov: novye vozmozhnosti.